The Use of Agitated Saline, Albumin, or a Propofol-albumin Mixture for Enhanced Contrast in Bubble Studies During Transesophageal Echocardiographic Examinations

Trial Profile

The Use of Agitated Saline, Albumin, or a Propofol-albumin Mixture for Enhanced Contrast in Bubble Studies During Transesophageal Echocardiographic Examinations

Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Sep 2016

At a glance

  • Drugs Albumin human (Primary) ; Propofol (Primary)
  • Indications Sedation
  • Focus Diagnostic use
  • Most Recent Events

    • 16 Sep 2016 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
    • 16 Sep 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Nov 2016.
    • 13 Jul 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Oct 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top